Literature DB >> 26721656

Inhospital and Post-discharge Changes in Renal Function After Transcatheter Aortic Valve Replacement.

John E A Blair1, Kent Brummel2, Julie L Friedman3, Prashant Atri4, Ranya N Sweis2, Hyde Russell2, Mark J Ricciardi2, S Chris Malaisrie2, Charles J Davidson2, James D Flaherty5.   

Abstract

The aim of this study was to determine the influence of inhospital and post-discharge worsening renal function (WRF) on prognosis after transcatheter aortic valve replacement (TAVR). Severe chronic kidney disease and inhospital WRF are both associated with poor outcomes after TAVR. There are no data available on post-discharge WRF and outcomes. This was a single-center study evaluating all TAVR from June 1, 2008, to June 31, 2014. WRF was defined as an increase in serum creatinine of ≥0.3 mg/dl. Inhospital WRF was measured from day 0 until discharge or day 7 if the hospitalization was >7 days. Post-discharge WRF was measured at 30 days after discharge. Descriptive statistics, Kaplan-Meier time-to-event analysis, and multivariate logistic regression were used. In a series of 208 patients who underwent TAVR, 204 with complete renal function data were used in the inhospital analysis and 168 who returned for the 30-day follow-up were used in the post-discharge analysis. Inhospital WRF was seen in 28%, whereas post-discharge WRF in 12%. Inhospital and post-discharge WRF were associated with lower rates of survival; however, after multivariate analysis, only post-discharge WRF remained a predictor of 1-year mortality (hazard ratio 1.18, p = 0.030 for every 1 mg/dl increase in serum creatinine). In conclusion, the rate of inhospital WRF is higher than the rate of post-discharge WRF after TAVR, and post-discharge WRF is more predictive of mortality than inhospital WRF.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26721656     DOI: 10.1016/j.amjcard.2015.11.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and Registry.

Authors:  Nirat Beohar; Darshan Doshi; Vinod Thourani; Hanna Jensen; Susheel Kodali; Feifan Zhang; Yiran Zhang; Charles Davidson; Patrick McCarthy; Michael Mack; Samir Kapadia; Martin Leon; Ajay Kirtane
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

Review 2.  Chronic kidney disease and transcatheter aortic valve implantation.

Authors:  Yuya Adachi; Masanori Yamamoto
Journal:  Cardiovasc Interv Ther       Date:  2022-05-05

3.  Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement.

Authors:  Guy Witberg; Tali Steinmetz; Uri Landes; Rotem Pistiner Hanit; Hefziba Green; Shira Goldman; Hana Vaknin-Assa; Pablo Codner; Leor Perl; Benaya Rozen-Zvi; Ran Kornowski
Journal:  JAMA Netw Open       Date:  2021-03-01

4.  Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment.

Authors:  Beata Bobrowska; Ewa Wieczorek-Surdacka; Olga Kruszelnicka; Bernadeta Chyrchel; Andrzej Surdacki; Dariusz Dudek
Journal:  Int J Mol Sci       Date:  2017-04-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.